证券简称：赛维时代 证券代码：301381 赛维时代科技股份有限公司 （草案） 赛维时代科技股份有限公司 二〇二五年九月 赛维时代：2025 年限制性股票激励计划（草案） 声明 本公司董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或权益归属安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 I 赛维时代：2025 年限制性股票激励计划（草案） 特别提示 一、本激励计划系依据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司股权激励管理办法》《深圳证券交易所创业板股票上市规则》《深圳 证券交易所创业板上市公司自律监管指南第 1 号——业务办理》等其他有关法律 法规、规章、规范性文件，以及《赛维时代科技股份有限公司章程》制订。 二、本激励计划的激励工具为限制性股票（第二类限制性股票），股票来源 为赛维时代科技股份有限公司（以下简称"公司"或"本公司 ...

本激励计划有效期为自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回 购注销之日止，最长不超过60个月。 弘元绿能（603185）(603185.SH)披露2025年限制性股票激励计划(草案)，公司拟向激励对象授予的限制 性股票合计不超过542.27万股(首次授予433.82万股)，首次授予的激励对象总人数为193人，限制性股票 的授予价格为每股11.61元。 ...

格隆汇9月5日丨致欧科技(301376.SZ)公布2025年限制性股票激励计划，本激励计划拟向激励对象授予 权益总计不超过354.74万股，占本激励计划草案公告时公司股本总额的0.88%。本次授予为一次性授 予，无预留权益。截至本激励计划草案公告日，公司不存在仍在有效期内的股权激励计划。公司全部在 有效期内的股权激励计划所涉及的标的股票总数累计未超过公司股本总额的20%。本激励计划中任何一 名激励对象通过全部在有效期内的股权激励计划所获授的本公司股票数量未超过公司股本总额的1%。 ...

格隆汇9月5日丨赛维时代(301381.SZ)公布2025年限制性股票激励计划，本激励计划拟向激励对象授予 403.4582万股限制性股票，约占本激励计划公告时公司股本总额的1.00%。其中首次授予399.7060万 股，约占本激励计划公告时公司股本总额的0.991%，约占本激励计划拟授予总额的99.07%，预留授予 3.7522万股，约占本激励计划公告时公司股本总额的0.009%，约占本激励计划拟授予总额的0.93%。 截至本激励计划公告时，公司全部有效期内的股权激励计划所涉及的标的股票数量累计未超过本激励计 划公告时公司股本总额的20.00%，任何一名激励对象通过全部在有效期内的股权激励计划获授的本公 司股票，累计未超过本激励计划公告时公司股本总额的1.00%。 ...

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng (Shenzhen) Law Firm addresses the adjustment of the grant price for the 2024 restricted stock incentive plan of Xiamen TeBao Biological Engineering Co., Ltd. and the granting of reserved restricted stocks to the incentive objects of the plan [1][2][3] Group 1: Adjustment of Grant Price - The grant price for the 2024 restricted stock incentive plan has been adjusted to 39.18 yuan per share from the previous price of 39.80 yuan per share due to a cash dividend distribution of 0.62 yuan per share [8][9][11] - The adjustment was approved by the company's board of directors and is in compliance with the relevant regulations of the Management Measures for Equity Incentives of Listed Companies and the company's incentive plan [7][10] Group 2: Reserved Stock Granting - The company plans to grant 1.2 million shares of restricted stock to 372 eligible incentive objects on September 4, 2025, at the adjusted price of 39.18 yuan per share [11][12] - The granting conditions for the reserved stocks have been met, and the company has fulfilled the necessary approval and authorization processes [10][12] Group 3: Compliance and Disclosure - The company has complied with the necessary legal and regulatory requirements for the adjustment and granting of the incentive plan, ensuring that all actions are in line with the applicable laws and regulations [10][12] - The company is required to continue fulfilling its information disclosure obligations as the incentive plan progresses [12]

上海荣正企业咨询服务（集团）股份有限公司 关于 厦门特宝生物工程股份有限公司 预留授予相关事项 之 证券简称：特宝生物 证券代码：688278 独立财务顾问报告 目 录 （二）本次实施的限制性股票激励计划与股东大会审议通过的限制性股票激 一、释义 生物工程股份有限公司 2024 年限制性股票激励计划（草案）》。 满足相应的归属条件后分次获得并登记的本公司 A 股普通股股票。 员、核心技术人员以及公司董事会认为需要激励的其他员工。 作废失效的期间 为。 足的获益条件。 必须为交易日。 息披露》 二、声明 本独立财务顾问对本报告特作如下声明： （一）本独立财务顾问报告所依据的文件、材料由特宝生物提供，本激励 计划所涉及的各方已向独立财务顾问保证：所提供的出具本独立财务顾问报告 所依据的所有文件和材料合法、真实、准确、完整、及时，不存在任何遗漏、 虚假或误导性陈述，并对其合法性、真实性、准确性、完整性、及时性负责。 本独立财务顾问不承担由此引起的任何风险责任。 （二）本独立财务顾问仅就本次限制性股票激励计划预留授予相关事项对 特宝生物股东是否公平、合理，对股东的权益和上市公司持续经营的影响发表 意见，不构成对公司的 ...

Core Viewpoint - The company conducted a self-examination regarding insider trading related to its 2025 Restricted Stock Incentive Plan, confirming that no insider trading occurred among the relevant parties during the specified period [1][3]. Group 1: Self-Examination Process - The self-examination covered the period from February 18, 2025, to August 18, 2025, focusing on stock trading activities of insider information personnel and incentive recipients [1]. - The examination was conducted in accordance with the relevant laws and regulations, with verification from the China Securities Depository and Clearing Corporation [1]. Group 2: Trading Activities of Insiders - During the self-examination period, only one entity, Guotai Junan Securities Co., Ltd., was found to have engaged in stock trading, while other insider information personnel did not engage in any trading activities [2]. - A total of 25 incentive recipients were identified to have traded the company's stock, but they acted based on publicly available information and independent judgment [2][3]. Group 3: Conclusion of Self-Examination - The company confirmed that appropriate confidentiality measures were in place during the planning and discussion of the incentive plan, and no insider trading was detected among the relevant parties [3]. - The findings align with the regulations set forth in the Management Measures for Equity Incentives, indicating no violations of insider trading laws [3].

Core Points - The company has reviewed and approved the list of incentive recipients for the 2025 Second Phase Restricted Stock Incentive Plan, confirming that all recipients meet the necessary legal and regulatory requirements [1][2] - The initial grant date for the incentive plan is set for September 5, 2025, with a price of 12.96 yuan per share for a total of 635,000 shares to be granted to 10 eligible recipients [2] Summary by Sections Incentive Plan Overview - The 2025 Second Phase Restricted Stock Incentive Plan has been established in accordance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1] - The plan aims to incentivize key management personnel and core staff, excluding independent directors, foreign employees, and major shareholders [2] Eligibility Criteria - The company has confirmed that all selected incentive recipients comply with the conditions outlined in the Management Measures and Listing Rules, ensuring their eligibility for the incentive plan [2] - Specific disqualifications for potential recipients include recent sanctions by the securities exchange or regulatory bodies, major legal violations, and other conditions as defined by law [1] Grant Details - The board and the remuneration committee have agreed on the legitimacy and effectiveness of the recipient list, with the conditions for the initial grant being fulfilled [2] - The total number of shares to be granted is 635,000, distributed among 10 recipients at a price of 12.96 yuan per share [2]

Core Viewpoint - The company has adjusted the grant price of the 2024 restricted stock incentive plan from 39.80 CNY per share to 39.18 CNY per share due to the implementation of the annual profit distribution plan [5][6][7]. Group 1: Decision-Making Process - The board of directors and the supervisory board approved the adjustment of the grant price during their respective meetings held on September 4, 2025 [1][5]. - The adjustment follows the procedures outlined in the company's 2024 restricted stock incentive plan draft and was authorized by the shareholders at the first extraordinary general meeting of 2024 [2][3]. Group 2: Adjustment Details - The adjustment was made based on the profit distribution plan approved at the 2024 annual general meeting, which included a cash dividend of 0.62 CNY per share [6]. - The formula used for the adjustment is P = P0 - V, where P0 is the original grant price, V is the cash dividend per share, and P is the adjusted grant price [6]. Group 3: Impact of Adjustment - The adjustment of the grant price is a result of the annual profit distribution and will not have a substantial impact on the company's financial status or operating results [6][7]. - The supervisory board confirmed that the adjustment complies with relevant regulations and does not harm the interests of the company or its shareholders [7]. Group 4: Legal Opinions - The company has obtained necessary approvals for the adjustment, ensuring compliance with relevant regulations and guidelines [7][8]. - The conditions for the reserved portion of the incentive plan have been met, and the company will continue to fulfill its information disclosure obligations as the incentive plan progresses [8].

证券代码：300644 证券简称：南京聚隆 公告编号：2025-102 债券代码：123209 债券简称：聚隆转债 南京聚隆科技股份有限公司 关于向 2025 年第二期限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： ? 限制性股票首次授予数量：63.50 万股 ? 限制性股票首次授予价格：12.96 元/股 ? 股权激励方式：第二类限制性股票 南京聚隆科技股份有限公司（以下简称"公司"）2025 年第二期限制性股票 激励计划规定的限制性股票首次授予条件已成就，根据公司 2025 年第二次临时 股东大会的授权，公司于 2025 年 9 月 5 日召开了第六届董事会第十七次会议， 会议审议通过了《关于向 2025 年第二期限制性股票激励计划激励对象首次授予 限制性股票的议案》，确定以 2025 年 9 月 5 日为首次授予日，向 10 名激励对象 授予限制性股票 63.50 万股，授予价格为 12.96 元/股。现将有关事项说明如下： 一、激励计划简述 （一）激励工具：第二类限制性股票 （二）标 ...